OSELLA, Domenico
 Distribuzione geografica
Continente #
NA - Nord America 9.352
EU - Europa 8.565
AS - Asia 4.039
SA - Sud America 766
AF - Africa 120
Continente sconosciuto - Info sul continente non disponibili 24
OC - Oceania 3
Totale 22.869
Nazione #
US - Stati Uniti d'America 9.207
IE - Irlanda 2.351
SE - Svezia 1.687
DE - Germania 1.455
SG - Singapore 1.358
UA - Ucraina 1.105
CN - Cina 961
HK - Hong Kong 865
FI - Finlandia 657
BR - Brasile 612
RU - Federazione Russa 555
VN - Vietnam 348
IT - Italia 347
GB - Regno Unito 182
IN - India 162
KR - Corea 109
CA - Canada 100
FR - Francia 70
AR - Argentina 69
BJ - Benin 52
ID - Indonesia 42
IR - Iran 42
BD - Bangladesh 38
PL - Polonia 36
MX - Messico 35
BE - Belgio 32
EC - Ecuador 28
TR - Turchia 28
EU - Europa 23
JP - Giappone 23
ZA - Sudafrica 20
ES - Italia 16
PY - Paraguay 15
UZ - Uzbekistan 14
NL - Olanda 13
CO - Colombia 12
LT - Lituania 12
RO - Romania 12
AT - Austria 11
MA - Marocco 11
CL - Cile 10
SA - Arabia Saudita 9
VE - Venezuela 9
EG - Egitto 8
IQ - Iraq 7
TN - Tunisia 7
AL - Albania 6
DZ - Algeria 6
KE - Kenya 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 4
IL - Israele 4
AU - Australia 3
GR - Grecia 3
HR - Croazia 3
JO - Giordania 3
NP - Nepal 3
PA - Panama 3
BA - Bosnia-Erzegovina 2
BW - Botswana 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
KZ - Kazakistan 2
NO - Norvegia 2
OM - Oman 2
PE - Perù 2
PK - Pakistan 2
RS - Serbia 2
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CH - Svizzera 1
CR - Costa Rica 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
NG - Nigeria 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RE - Reunion 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 22.869
Città #
Dublin 2.344
Jacksonville 1.877
Dearborn 984
Hong Kong 861
Chandler 805
Wilmington 572
Singapore 496
Beijing 495
Ashburn 414
Lawrence 319
Princeton 319
Moscow 263
Ann Arbor 255
San Mateo 253
Los Angeles 217
Andover 202
New York 192
Buffalo 155
Piemonte 133
Ho Chi Minh City 130
Seoul 108
Munich 102
Boardman 99
Woodbridge 93
Düsseldorf 89
Houston 89
Philadelphia 80
São Paulo 65
Hanoi 61
Toronto 61
Redondo Beach 59
Bremen 58
Cotonou 52
Dallas 49
Grafing 49
Helsinki 46
Hefei 45
Nanjing 45
Norwalk 41
Kunming 36
Santa Clara 34
Brussels 32
Atlanta 29
Monmouth Junction 28
Leawood 27
Frankfurt am Main 26
Stockholm 25
Denver 23
Rio de Janeiro 23
Tokyo 23
Warsaw 22
Fairfield 21
Brooklyn 20
Novara 20
Biên Hòa 19
Chicago 19
London 19
Montreal 19
Orem 19
Zanjan 19
Belo Horizonte 17
Guangzhou 17
Cave Creek 16
Jinan 16
Nuremberg 16
Turku 16
Chennai 15
Poplar 15
Tianjin 15
Ankara 14
Da Nang 14
Hebei 14
Phoenix 14
Ardabil 13
Bexley 13
Boston 13
Mumbai 13
Seattle 13
Shenyang 13
Tashkent 13
Mexico City 12
Augusta 11
Hải Dương 11
Kocaeli 11
Manchester 11
Brasília 10
Curitiba 10
Guarulhos 10
Guayaquil 10
Jakarta 10
Thái Bình 10
Wroclaw 10
Johannesburg 9
Porto Alegre 9
Wuhan 9
Cambridge 8
Dong Ket 8
Haiphong 8
Ninh Bình 8
Quito 8
Totale 13.563
Nome #
Antiproliferative Activity of Pt(IV) Conjugates Containing the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ketoprofen and Naproxen 135
Cisplatin and valproate released from the bifunctional [Pt(IV)Cl2(NH3)2(valproato)2] antitumor prodrug or from liposome formulations: who does what? 126
195Pt NMR chemical shift: a chemometric approach 123
Transition metal carbonyl clusters in biology: A futile or niche research area? 122
Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells 120
Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure-activity relationship modeling 117
Assessment of the anticancer potentiality of a new platinum nanoparticulate coniugate 116
Antiproliferative Activity of PtII Complexes with Carboxylated Phosphanes in Chelated or Ring-Opened Forms 116
Beyond the Pt(II)-based chemotherapy: Pt(IV) complexes as oral anticancer pro-drugs 114
Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs 114
Different strategies to exploit Pt(IV) complexes as pro-drugs 113
13C Solid State MAS NMR spectra of [M3(CO)12] complexes (M = Ru and Os). Evidence for motional effects in [Ru3(CO)12] 113
Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs 110
199Hg NMR of mercury-bridged transition metal clusters 109
The antiproliferative activity of dicobalt-hexacarbonyl-aspirin complex on different malignant pleural mesotelioma phenotypes 108
A different way for the oxidation of the Pt(II) complexes 108
Antioxidant Composition of a Selection of Italian Red Wines and Their Corresponding Free-Radical Scavenging Ability 108
A New Entry to Asymmetric Platinum(IV) Complexes via Oxidative Chlorination 107
Haemolymph from Mytilus galloprovincialis: Response to copper and temperature challenges studied by 1H-NMR metabonomics 107
Activation of alkynes by transition metals 106
Moving the paradigm in platinum-based chemotherapy from Pt(II) to Pt(IV) complexes? 105
Appraisal of the Redox Behaviour of the Antimetastatic Ruthenium(III) Complex [ImH][RuCl4(DMSO)(Im)], NAMI-A 105
Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 105
1H-NMR SPIN-LATTICE RELAXATION STUDIES OF HYDRIDOMETAL CLUSTERS OF RUTHENIUM AND OSMIUM 103
17O NMR spectroscopy of transition metal carbonyls 102
Experimental (RP-HPLC) and theoretical (MIFs) study of the lipophilicity of a series of Pt(IV) complexes 102
Estradiol as Carrier For Selective Delivery of Cytotoxic Pt(II) Complexes to Cancer Cell Nuclei 101
Cytotoxicity of some Pt(II)-diamine complexes: a QSAR evaluation of the effect of chelating arms and leaving groups 101
ACTIVATION OF THE M-CO BOND IN TRANSITION-METAL COMPLEXES. FE2(CO)6(SME)2 AND PHOSPHINE-SUBSTITUTED DERIVATIVES AS GOOD CATALYSTS IN METAL-CARBONYL SUBSTITUTION-REACTIONS 101
Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer 101
Water stability and cytotoxic activity relationship of a series of ferrocenium salts. characterization of the radical production during the degradation process. 100
Esr insights on the radical production during the degradation process relationship of some ferrocenium derivatives. Determination of their water stability and cytotoxic activity 100
Host-guest inclusion systems of Pt(IV)-bis(benzoato) anticancer drug candidates and cyclodextrins 99
Functionalized nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 99
Antitumor platinum(IV) pro-drugs: synthesis, characterization, cytotoxicity and QSAR analysis 98
New Platinum-Based Prodrug Pt(IV)Ac-POA: Antitumour Effects in Rat C6 Glioblastoma Cells 98
The cisplatin-based Pt(IV)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions 97
A novel bonding scheme of an allene system in a transition metal cluster complex. Molecular structure of μ3-η-(1-methyl-3-ethyl-3-allenyl)-μ-hydrido-triangulo- tris(tricarbonylruthenium)(3Ru-Ru) 96
Experimental and molecular modeling approaches to determine the lipophilicity of a Pt(IV) pro-drugs 96
Electrochemical measurements confirm the preferential bonding of the antimetastatic complex [ImH][RuCl(4)(DMSO)(Im)] (NAMI-A) with proteins and the weak interaction with nucleobases 96
Effect of arbuscular mycorrhizal and bacterial inocula on nitrate concentration in mesocosms simulating a wastewater treatment system relying on phytodepuration 96
Hybrid inorganic (nonporous silica)/organic (alginate) core-shell platform for targeting a cisplatin-based Pt(IV) anticancer prodrug 96
Effects of dimethylsulfoxide and ethanol on the cytotoxic activity of titanocene dichloride 94
A 13C NMR investigation of stereochemical non rigidity in hydrido olefinic carbonyl clusters of ruthenium 94
Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: How long the organic chain should be? 93
Polyanionic Biopolymers for the Delivery of Pt(II) Cationic Antiproliferative Complexes 93
A view on multi-action Pt(IV) antitumor prodrugs 93
A multi-methodological inquiry of the behavior of cisplatin-based Pt(IV) derivatives in the presence of bioreductants with a focus on the isolated encounter complexes 93
Oxidative degradation of 1,5-naphthalenedisulfonic acid (NDS) in aqueous solutions by microwave irradiation in the presence of H2O2 92
Solvolysis of a Series of Cisplatin-Like Complexes – Comparison between DNA-Biosensor and Conductivity Data 92
Cis,cis,trans-[PtIVCl2(NH3)2(perillato)2], a dual-action prodrug with excellent cytotoxic and antimetastatic activity 92
A MECHANISTIC STUDY OF THE REACTION OF H2OS3(CO)10 WITH TERMINAL ALKYNES 91
Esr insights on the radical production during the degradation process relationship of some ferrocenium derivatives. Determination of their water stability and cytotoxic activity 91
Synthesis, characterization and antiproliferative activity of platinum(IV) derivates of picoplatin 91
Solution structure and dynamics of H2Ru4(CO)13 90
An inspection into the class of bis(alkyne)-undecacarbonyl-quadro-tetraruthenium complexes. Crystal structure and dynamic behaviour of Ru4(CO)11 (μ4, η2-MeC2Ph)2 90
The structures and fluxional behaviour of the binary carbonyls; A new approach. Part 3. The fluxional behaviour of [Fe3(CO)11L], L = PR3 or P(OR)3 90
Water stability and cytotoxic activity relationship of a series of ferrocenium salts. characterization of the radical production during the degradation process 89
Authentication and traceability study of Hazelnuts from piedmont, italy 89
13C N.M.R. spectra of highly 13CO-enriched metal carbonyls: Observation of 2JCC cis coupling constants 89
Synthesis and characterization of cyclohexane-1R,2R-diamine-based Pt(iv) dicarboxylato anticancer prodrugs: their selective activity against human colon cancer cell lines 89
Bifunctional Pt-ethacrynic acid conjugates for malignant mesothelioma 88
Classical Pt(II) anticancer complexes revised in view of drug targeting and delivery 88
May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs? 88
An unsymmetric cisplatin-based Pt(IV) derivative containing 2-(2-propynyl)octanoate: A very efficient multi-action antitumor prodrug candidate 88
Evaluation of Platinum–Ethacrynic Acid Conjugates in the Treatment of Mesothelioma 86
In vitro anti-mesothelioma activity of cisplatin–gemcitabine combinations: evidence for sequence-dependent effects 86
Synthesis of PtIV-Biomolecule Conjugates through Click Chemistry 86
Pt-195 NMR spectroscopy: A chemometric approach 85
Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin 85
Unprecedented one-pot synthesis of an unsymmetrical cisplatin-based Pt(IV)-acetamidato complex 85
Wine Traceability with Rare Earth Elements 85
Isomerisation of Pentenes Catalysed by Ruthenium Cluster Carbonyls 85
Cellular uptake of antitumor platinum(II)-complexes evaluated by means of ICP-MS technique 84
Iron-57 satellites in 13C NMR spectra: an aid to elucidation of "hidden-processes" in the dynamics of metal carbonyls 83
Gas-phase UV photoelectron spectra of some edge-bridged decacarbonyltriosmium clusters 83
Electronic Communication in [Co2(CO)6]2-diyne and [Co2(CO)4(dppm)]2-diyne Complexes 83
An experiment in the electrokinetic removal of copper from soil contaminated by the brass industry 83
Pros and cons of bifunctional platinum drugs: two are (not always) better than one 83
Two are (not always) better than one: the case of bifunctional platinum(IV) drugs 83
Pt(IV) complexes as anticancer prodrugs 83
The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells 83
The effects of sulphur dioxide on wine metabolites: New insights from 1H NMR spectroscopy based in-situ screening, detection, identification and quantification 83
Cytotoxicity of cis-platinum(II) conjugate models. The effect of chelating arms and leaving groups on cytotoxicity: A quantitative structure-activity relationship approach 82
Pt(IV) – histone deacetylase inhibitor conjugates for citotoxicity studies on MPM cells 82
UV photoelectron spectra of some organometallic carbonyl osmium clusters 82
High-field 17O NMR spectroscopy: Solution structures and dynamics of 17O enriched Co4(CO)12 and HFeCo3(CO)12 81
Bidentate and tridentate pyrazolyl-containing Pt(II) complexes: synthesis, characterization and in vitro evaluation 81
13C-13C coupling constants in μ2- and μ4-(η2-acetylene) complexes of cobalt 81
Wine evolution during bottle aging, studied by 1H NMR spectroscopy and multivariate statistical analysis 81
Antiproliferative effect of ferrocifen drug candidates on malignant pleural mesothelioma cell lines 80
Kinetic deuterium isotope effects on μ-hydride and carbonyl ligand migrations 79
Relationships between structure and ligand dynamics in organometal clusters 79
Solution structures and dynamics of Co4(CO)12 and HFeCo3(CO)12-xLx (x = 0-3; L = group V Ligand) 79
KINETIC DEUTERIUM-ISOTOPE EFFECTS ON LIGAND MIGRATIONS IN METAL-HYDRIDES .2. 79
Ferrole-estradiol complex as a test for receptor dimerization 79
Bifunctional Ethacrynic Acid – Pt Conjugates: In vitro Treatment of Malignant Pleural Mesothelioma 79
COMBINED UV-PES AND THEORETICAL-STUDY OF BINUCLEAR FE2(CO)6(C4H4), RU2(CO)6(C4H4), OS2(CO)6(C4H4) COMPLEXES 78
Assessment of the in vivo antiproliferative activity of a novel platinum nanoparticulate pharmacophore 78
Oxidative degradation of 1,5-naphthalenedisulfonic acid in aqueous solutions by UV-photolysis in the absence and presence of H2O2 78
Totale 9.448
Categoria #
all - tutte 128.483
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 128.483


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.302 0 0 0 0 0 31 332 7 337 58 421 116
2021/20222.542 175 29 585 363 117 1 257 43 139 35 347 451
2022/20235.085 338 133 303 231 418 590 81 277 2.426 39 161 88
2023/20241.162 120 103 102 25 269 1 244 10 4 6 126 152
2024/20252.605 24 44 105 101 106 186 244 187 809 343 85 371
2025/20263.962 411 379 806 1.414 781 171 0 0 0 0 0 0
Totale 23.090